If your doctor mentions screening you for prostate cancer, it’s time to pay full attention and be an active participant in your medical care. You may be at a higher risk because of your age (over 50), ...

A systematic review and meta-analysis compares survival outcomes with whole-pelvic vs prostate-only radiotherapy in men with clinically node-negative high-risk localized prostate cancer.

With prostate cancer survival continuing to improve, the long-term cardiovascular consequences of androgen deprivation ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown pathway that prostate ...

Men undergoing hormone therapy for advanced prostate cancer often experience severe hot flashes, according to doctors. Gibbs ...

AstraZeneca will delay the withdrawal of breast cancer drug Zoladex from the Australian market while it attempts to ...

Learn how prostate cancer is treated at each stage, from active surveillance and surgery to radiation, hormone therapy, and targeted drugs.

Carlsbad resident Joe Tarka, 78, has returned to playing baseball after being declared cancer-free following treatment from ...

Manojkumar Bupathi, MD, MS, discusses the changes that biomarker-based treatment brings to hormone-sensitive prostate cancer.

Lifestyle Intervention Mitigates ADT-Associated Adverse Effects in Prostate Cancer / ADT, androgen deprivation therapy, ...

Triptorelin, already listed for prostate cancer, should have unrestricted use, the Pharmaceutical Benefits Advisory Committee says Follow our Australia news live blog for latest updates Get our ...

Triptorelin, a decapeptide analog of gonadotropin-releasing hormone (GnRH), is emerging as a focal point in basic and translational research exploring neuroendocrine modulation. Featuring increased ...